Literature DB >> 21633808

Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy.

María Socorro Alforja1, Noelia Sabater2, Joan Giralt2, Alfredo Adán2,3, Laura Pelegrín2, Ricardo Casaroli-Marano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21633808     DOI： 10.1007/s10384-011-0038-y

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Ultra widefield imaging of peripheral exudative hemorrhagic chorioretinopathy.

Authors:  Irena Tsui; Atul Jain; Sumit Shah; Steven D Schwartz; Tara A McCannel
Journal:  Semin Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 1.975

2.  Peripheral exudative hemorrhagic chorioretinopathy.

Authors:  W H Annesley
Journal:  Trans Am Ophthalmol Soc       Date:  1980

3.  Peripheral exudative and hemorrhagic chorio-retinopathy...the peripheral form of age-related macular degeneration? Report on 2 cases.

Authors:  N Collaer; C James
Journal:  Bull Soc Belge Ophtalmol       Date:  2007

4.  Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.

Authors:  Irmela Mantel; Sylvie Uffer; Leonidas Zografos
Journal:  Am J Ophthalmol       Date:  2009-10-02       Impact factor: 5.258

5.  Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes.

Authors:  Carol L Shields; Pedro F Salazar; Arman Mashayekhi; Jerry A Shields
Journal:  Ophthalmology       Date:  2009-01-20       Impact factor: 12.079
  5 in total
  6 in total

1.  Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy.

Authors:  E Y Pinarci; I Kilic; S A Bayar; S Sizmaz; I Akkoyun; G Yilmaz
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

2.  Novel thermosensitive pentablock copolymers for sustained delivery of proteins in the treatment of posterior segment diseases.

Authors:  Sulabh P Patel; Ravi Vaishya; Xiaoyan Yang; Dhananjay Pal; Ashim K Mitra
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

3.  Clinical Features and Course of Patients with Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Zafer Cebeci; Yasemin Dere; Şerife Bayraktar; Samuray Tuncer; Nur Kır
Journal:  Turk J Ophthalmol       Date:  2016-10-17

4.  Surgical Management of Hemorrhagic Retinal Detachment Secondary to Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Valmore A Semidey; Abdulaziz A Al Taisan; Patrik Schatz; Ibrahim Taskintuna; Marco Mura
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

5.  Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab.

Authors:  Kei Takayama; Tosio Enoki; Teruo Kojima; Sho Ishikawa; Masaru Takeuchi
Journal:  Clin Ophthalmol       Date:  2012-06-07

6.  Updated Systematic Review and Clinical Spectrum of Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Abdulrahman H Badawi; Valmore A Semidey; Moustafa Magliyah; Hassan Al-Dhibi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.